信息搜索
信息关键字:医药
 

共有1868条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]

·太平洋证券:医药板块回调明显关注半年报绩优标的2022-7-31 17:43:23
·人福医药7月29日主力资金净卖出7310.73万元2022-7-30 9:30:50
·中国医药7月29日主力资金净卖出1.37亿元2022-7-30 8:44:33
·东亚药业:两款原料药获得韩国原料医药品登陆证书2022-7-30 2:17:28
·未名医药:公司第一大股东、实际控制人拟变更2022-7-30 0:49:35
·葵花药业拟投资5400万设立全资子公司北京葵花医药研究有限责任公司2022-7-29 22:51:00
·每日八张图:白酒、医药股成砸盘先锋A股再度跳水!八月行情能否稳住?2022-7-29 21:23:03
·怡亚通:拟挂牌转让云南腾瑞医药60%的股权2022-7-29 21:17:54
·归母净利降45%!销售费用约为研发费用10倍,沃华医药如何突围?2022-7-29 16:05:00
·吹尽狂沙始到金!百利天恒科创板顺利过会,系成都市第6家生物医药科创板公司2022-7-29 15:06:07
·中报大幕徐徐拉开基金增持两大医药龙头股2022-7-28 14:08:09
·复星医药逾44亿定增敲定冯柳买入20亿获阿兹夫定独家商业化权益丰富产品线2022-7-28 12:36:12
·东吴证券点评复星医药:就首个国产新冠小分子口服药达成战略合作有望带来较大业绩弹性2022-7-28 12:23:57
·人福医药股东王学海减持106万股套现1884.83万2022年第一季度公司净利9.33亿2022-7-27 21:36:06
·复星医药与国药控股签署战略协议,加速推进阿兹夫定片全国渠道网络覆盖2022-7-27 19:05:20
·从药明康德财报看医药股是否触底?2022-7-27 17:24:10
·千亿医药巨头定增出炉!高毅获配20亿!刚拿下新冠口服药独家商业化权利2022-7-27 13:05:57
·中泰证券点评复星医药:独家商业化首个国产新冠口服药,有望获得可观收益2022-7-27 11:36:36
·【公告速递】碧水源控股股东拟要约收购复星医药定增高毅获配近20亿元盛新锂能等披露半年报2022-7-27 1:40:49
·复星医药44.8亿元定增落地,高毅冯柳“拿下”20亿占半壁江山2022-7-27 0:29:09

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94]